A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study

Sheri L. Spunt, Douglas S. Hawkins, Yueh-Yun Chi et al.|The Lancet Oncology|2019

Cited by 182